UHT · Universal Health Realty Income Trust - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.53M | - | $25.30M | $24.87M | $24.55M | - | $24.49M | $24.73M | $25.14M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $15.57M | - | $16.91M | $16.02M | $15.51M | - | $16.00M | $15.15M | $15.68M | - |
| D&A | $6.95M | - | $7.90M | $6.99M | $6.84M | - | $7.01M | $6.81M | $6.81M | - |
| Operating Income | $8.96M | - | $8.39M | $8.84M | $9.03M | - | $8.49M | $9.58M | $9.46M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | $5.02M | - | $4.02M | $4.49M | $4.78M | - | $4.00M | $5.28M | $5.30M | - |
| EPS - Basic | $0.36 | - | $0.29 | $0.33 | $0.35 | - | $0.29 | $0.38 | $0.38 | - |
| EPS - Diluted | $0.36 | - | $0.29 | $0.32 | $0.34 | - | $0.29 | $0.38 | $0.38 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.06M | $6.69M | $6.92M | $6.55M | $6.97M | $7.10M | $6.37M | $5.58M | $7.70M | $8.21M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $563.76M | $564.91M | $568.04M | $573.02M | $573.48M | $580.86M | $584.33M | $586.55M | $596.19M | $596.37M |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | - | $374.77M | - | - | - | $368.41M | - | - | - | $359.66M |
| Total Liabilities | $415.96M | $412.52M | $409.46M | $407.86M | $401.32M | $401.32M | $402.69M | $395.85M | $399.73M | $395.44M |
| Stockholders' Equity | $147.80M | $152.38M | $158.57M | $165.15M | $172.17M | $179.54M | $181.64M | $190.70M | $196.46M | $200.93M |
| Retained Earnings | $867.92M | $862.90M | $858.58M | $854.56M | $850.07M | $845.29M | $840.63M | $836.64M | $831.36M | $826.06M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $11.95M | - | - | - | $11.61M | - | - | - | $11.74M | - |
| Investing Cash Flow | ($4.46M) | - | - | - | ($1.90M) | - | - | - | ($8.95M) | - |
| Financing Cash Flow | ($7.12M) | - | - | - | ($9.84M) | - | - | - | ($3.31M) | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 36.5% | - | 33.2% | 35.6% | 36.8% | - | 34.7% | 38.7% | 37.6% | - |
| EBITDA margin | 64.9% | - | 64.4% | 63.7% | 64.7% | - | 63.3% | 66.3% | 64.7% | - |
| Net margin | 20.5% | - | 15.9% | 18.1% | 19.5% | - | 16.3% | 21.3% | 21.1% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | 0.9% | - | 0.7% | 0.8% | 0.8% | - | 0.7% | 0.9% | 0.9% | - |
| Return on equity | 3.4% | - | 2.5% | 2.7% | 2.8% | - | 2.2% | 2.8% | 2.7% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | 2.46 | - | - | - | 2.05 | - | - | - | 1.79 |
| Debt / Assets | - | 0.66 | - | - | - | 0.63 | - | - | - | 0.60 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 3.81 | 3.71 | 3.58 | 3.47 | 3.33 | 3.24 | 3.22 | 3.08 | 3.03 | 2.97 |
| Liabilities / Assets | 0.74 | 0.73 | 0.72 | 0.71 | 0.70 | 0.69 | 0.69 | 0.67 | 0.67 | 0.66 |
| Efficiency | ||||||||||
| Asset turnover | 0.04 | - | 0.04 | 0.04 | 0.04 | - | 0.04 | 0.04 | 0.04 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 112.4x | - | 135.1x | 124.9x | 120.5x | - | 157.8x | 103.0x | 96.6x | - |
| P / B | 3.8x | - | 3.4x | 3.4x | 3.3x | - | 3.5x | 2.8x | 2.6x | - |
| P / S | 22.9x | - | 21.5x | 22.3x | 23.1x | - | 25.9x | 21.9x | 20.2x | - |
| EV / EBITDA | 34.8x | - | 32.9x | 34.6x | 35.3x | - | 40.5x | 32.7x | 30.7x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -0.1% | - | 3.3% | 0.5% | -2.4% | - | 1.1% | 3.9% | 8.2% | - |
| Revenue CAGR (3y) | 1.8% | - | 4.5% | 3.9% | 3.4% | - | 4.9% | 5.8% | 6.7% | - |
| Revenue CAGR (5y) | 3.5% | - | 5.1% | 5.2% | 5.0% | - | 4.3% | 5.1% | 5.6% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -0.9% | - | -1.1% | -7.7% | -4.5% | - | 5.8% | 29.8% | 21.6% | - |
| Net income growth (YoY) | 5.1% | - | 0.5% | -14.9% | -9.9% | - | 3.2% | 51.8% | 18.9% | - |
| EPS growth (YoY) | 5.9% | - | 0.0% | -15.8% | -10.5% | - | 3.6% | 52.0% | 18.8% | - |
| EPS CAGR (3y) | 4.0% | - | -6.1% | -5.6% | -4.5% | - | -9.4% | -7.5% | -2.5% | - |
| EPS CAGR (5y) | -2.6% | - | -5.3% | -1.2% | 0.6% | - | -3.1% | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -14.2% | -15.1% | -12.7% | -13.4% | -12.4% | -10.6% | -13.6% | -12.0% | -11.6% | -12.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$99.19M totalReportable Segment Aggregation Before Other Operating Segment$99.19M · 100.0%
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing UNIVERSAL HEALTH REALTY INCOME TRUST against the 5 most active filers in the same SIC group.
Dividends
$2.97/share trailing 12 months · +1.4% YoY
| Ex-date | Per share |
|---|---|
| Mar 23, 2026 | $0.7450 |
| Dec 22, 2025 | $0.7450 |
| Sep 22, 2025 | $0.7400 |
| Jun 23, 2025 | $0.7400 |
| Mar 24, 2025 | $0.7350 |
| Dec 16, 2024 | $0.7350 |
| Sep 16, 2024 | $0.7300 |
| Jun 17, 2024 | $0.7300 |
| Mar 15, 2024 | $0.7250 |
| Dec 18, 2023 | $0.7250 |
| Sep 18, 2023 | $0.7200 |
| Jun 16, 2023 | $0.7200 |
| Mar 17, 2023 | $0.7150 |
| Dec 15, 2022 | $0.7150 |
| Sep 16, 2022 | $0.7100 |
| Jun 16, 2022 | $0.7100 |
| Mar 18, 2022 | $0.7050 |
| Dec 14, 2021 | $0.7050 |
| Sep 17, 2021 | $0.7000 |
| Jun 15, 2021 | $0.7000 |
| Mar 16, 2021 | $0.6950 |
| Dec 16, 2020 | $0.6950 |
| Sep 15, 2020 | $0.6900 |
| Jun 15, 2020 | $0.6900 |